Browse life science companies in Stevenage, including organisations based within the Stevenage Bioscience Catalyst ecosystem.
Automated bioreactor platform for cell and gene therapy manufacturing
microfluidX is a UK instruments company developing automated bioprocessing platforms for cell and gene therapy research and manufacturing. Its core product is a…
Preventing cancer therapy side effects with topical medicines
VasoDynamics is a clinical-stage pharmaceutical development company focused on preventing the debilitating side effects of cancer therapy. The company develops topical…
Antibody fragment drug conjugate platform for solid tumour oncology
Antikor Biopharma is a pre-clinical stage biotechnology company developing antibody fragment drug conjugates for the treatment of solid tumours. The company's proprietary platform…
Engineered bacteria to remodel the tumour microenvironment
Neobe Therapeutics is a UK synthetic biology company developing programmable live biotherapeutics that colonise solid tumours and disrupt the local microenvironment to enable…
Open innovation life sciences campus co-located with GSK
Stevenage Bioscience Catalyst (SBC) is a not-for-profit open innovation campus and the UK's first biomedical catalyst, established in 2012 through joint funding from GSK, Wellcome…
In vitro respiratory and inhalation toxicology testing services
ImmuONE is a contract research company specialising in in vitro inhalation toxicology and respiratory safety assessment. The company develops and applies human alveolar macrophage…
Combinatorial stem cell screening platform for therapy development
Plasticell is a biotechnology company developing cell and gene therapies and enabling drug discovery through its proprietary platform. The technology uses bead-based combinatorial…
AAV gene therapies for rare and neurological diseases
Spur Therapeutics is a clinical-stage biotechnology company developing adeno-associated virus-based gene therapies for serious chronic diseases. Its lead programme is a Phase I/II…
Precision oncology biotech targeting synthetic lethality in cancer
Tessellate Bio is a precision oncology company developing small molecule drugs that exploit synthetic lethality, the principle that certain genetic vulnerabilities in cancer cells…
Platform for controlled, repeatable cellular rejuvenation therapeutics
BioRes is a preclinical biotechnology company developing a platform for controlled, repeatable cellular rejuvenation. The company's approach aims to restore cellular function as a…
Targeting mitochondrial dysfunction in neurodegeneration
NRG Therapeutics is a clinical-stage neuroscience company developing small molecule inhibitors of the mitochondrial permeability transition pore as disease-modifying treatments…
AI-guided CRISPR platform developing precision-bred crop varieties
Phytoform Labs is a plant biotechnology company combining artificial intelligence and CRISPR-Cas gene editing to accelerate the development of novel crop traits. Its platform…